Cargando…
A new prodrug and bioactivity evaluation of methotrexate based on Chitosan
Methotrexate (MTX) is the most important drug used in the treatment of several kinds of cancers, such as colon cancer. However, this drug can cause a reduction in the target tissue bioavailability. It is administered orally and absorbed quickly. This study aimed to produce an anti-colon cancer prodr...
Autores principales: | Mohammed, Mohsin Omar, Alkubaisi, Hameed Madlool Mohammed, Haj, Nadia Qader |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306593/ https://www.ncbi.nlm.nih.gov/pubmed/32596525 http://dx.doi.org/10.1016/j.heliyon.2020.e04223 |
Ejemplares similares
-
Preparation and Bioactivity Assessment of Chitosan-1-Acetic Acid-5-Flurouracil Conjugates as Cancer Prodrugs
por: Mohammed, Mohsin O., et al.
Publicado: (2017) -
Synthesis and Biological Evaluation of Three New Chitosan
Schiff Base Derivatives
por: Haj, Nadia Q., et al.
Publicado: (2020) -
TSPO Ligand-Methotrexate Prodrug Conjugates: Design, Synthesis, and Biological Evaluation
por: Laquintana, Valentino, et al.
Publicado: (2016) -
Synthesis of Two Methotrexate Prodrugs for Optimizing Drug Loading into Liposomes
por: Di Francesco, Valentina, et al.
Publicado: (2021) -
A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery
por: Guo, Fuqiang, et al.
Publicado: (2016)